Dr. Manesh Dixit

Founder of First Time US Generics, Philadelphia, USA. & First Time US Pharmaceuticals (I) Pvt. Ltd., Navi Mumbai, India.

Qualification :

  • Bachelor of Pharmacy and Diploma of Pharmacy, Mumbai University
  • Ph.D. (Pharmaceutics), The Ohio State University

Dr. Manesh Dixit received his Ph.D. in Pharmaceutics from The Ohio State University in March, 1999. He joined The Ohio State University in September, 1994 after graduating with a pharmacy degree from the University of Mumbai in India.

Currently, Dr. Dixit is the president, Chairman and CEO of First Time US Generics LLC., which he founded. the company manufactures prescription branded and generic products including transdermal patches and oral solid dosage products for USA and foreign markets out of its FDA and DEA audited facilities in Miami, Philadelphia, Kansas city and Mumbai. In 2017, Dr. Dixit successfully acquired a large-scale commercial operation in Miami, Florida, an 180,000 sq. ft manufacturing facility, along with Nitr-Dur® (Nitroglycerin) Transdermal Infusion System from Merck Sharp & Dohme corp.

Prior to starting his business, he was a senior executive with multidisciplinary expertise in the pharmaceutical industry. His expertise included all aspects of pharmaceutical product development, FDA filing, the product launch, DEA matters and day to day plant operation. He is well-versed in the intricacies of regulatory strategies as well as in the resolution of patent and exclusivity issues and controlled substance compliance. He also passed the patent bar examination and is registered to practice before the USPTO.